Ignite Creation Date:
2024-05-05 @ 9:22 PM
Last Modification Date:
2024-10-26 @ 10:02 AM
Study NCT ID:
NCT00861705
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-17
First Post:
2009-03-12
Brief Title:
Paclitaxel With or Without Carboplatin andor Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Triple-Negative Breast Carcinoma |
| Male Breast Carcinoma |
| Stage IIA Breast Cancer AJCC v6 and v7 |
| Stage IIB Breast Cancer AJCC v6 and v7 |
| Stage IIIA Breast Cancer AJCC v7 |
Keywords: